mw33
mAbexperimentalCOVID-19
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 7, 2020 (NCT04533048)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, passive
SARS-CoV-2 immunity, passive
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04627584 | Phase 2 | Dec 29, 2020 | Mabwell |
| NCT04533048 | Phase 1 | Aug 7, 2020 | Fudan University, Mabwell |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mabwell | For profit | 2 | 2 | 2 | 2020 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1